NCT00086879 - Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme | Biotech Hunter

Enrollment

110

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2011

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

carmustine

DRUG

erlotinib hydrochloride

DRUG

temozolomide

Trial Locations (10)

Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon

Azienda Ospedaliera di Padova, Padua

Centre Regional Rene Gauducheau, Nantes-Saint Herblain

CHU Pitie-Salpetriere, Paris

U.Z. Gasthuisberg, Leuven

Centre Antoine Lacassagne, Nice

Institut Gustave Roussy, Villejuif

University Medical Center Rotterdam at Erasmus Medical Center, Rotterdam

Medisch Centrum Haaglanden, The Hague

Western Infirmary, Glasgow

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK